Modulation of CCR2 in rheumatoid arthritis: a double‐blind, randomized, placebo‐controlled clinical trial

CE Vergunst, DM Gerlag… - … : Official Journal of …, 2008 - Wiley Online Library
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …
被引用次数：245 相关文章

Modulation of CCR2 in rheumatoid arthritis-A double-blind, randomized, placebo-controlled clinical trial

CE Vergunst, DM Gerlag, L Lopatinskaya… - ARTHRITIS AND …, 2008 - biblio.ugent.be
Objective. CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

CE Vergunst, DM Gerlag, L Lopatinskaya… - Arthritis and …, 2008 - europepmc.org
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial

CE Vergunst, DM Gerlag… - Arthritis and …, 2008 - researchinformation.amsterdamumc …
OBJECTIVE: CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …
[PDF] academia.edu

[PDF][PDF] Modulation of CCR2 in Rheumatoid Arthritis

CE Vergunst, DM Gerlag, L Lopatinskaya… - ARTHRITIS & …, 2008 - academia.edu
Objective. CCR2 is a chemokine receptor ex-pressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …

[引用][C] Modulation of CCR2 in Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

C Vergunst, D Gerlag… - Arthritis and …, 2008 - researchnow.flinders.edu.au
Modulation of CCR2 in Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled
Clinical Trial — Research @ Flinders Skip to main navigation Skip to search Skip to main …

Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

CE Vergunst, DM Gerlag, L Lopatinskaya… - Arthritis & …, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p>
CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a subset of T …

Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

CE Vergunst, DM Gerlag… - … : Official Journal of …, 2008 - Wiley Online Library
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …

[引用][C] Modulation of CCR2 in Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

CE VERGUNST, DM GERLAG… - Arthritis and …, 2008 - pascal-francis.inist.fr
Modulation of CCR2 in Rheumatoid Arthritis : A Double-Blind, Randomized, Placebo-Controlled
Clinical Trial CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial

CE Vergunst, DM Gerlag… - Arthritis and …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …